Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aqua Maris Baby is an isotonic nasal solution developed by JGL Group, specifically formulated for the hygiene and care of the nasal passages in infants and young children. The product contains purified seawater from the Adriatic Sea, which is naturally rich in minerals and trace elements such as magnesium, calcium, and manganese. It works through a mechanical action to irrigate the nasal cavity, thinning and removing excess mucus, crusts, allergens, and pathogens. By moisturizing the nasal mucosa, it helps maintain the physiological state of the respiratory tract and supports the natural defense mechanisms of the nose. It is indicated for daily nasal hygiene, the relief of nasal congestion associated with colds or allergies, and the prevention of secondary respiratory infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isotonic seawater.